BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//New Jersey Alliance for Clinical and Translational Science - ECPv6.15.14//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:New Jersey Alliance for Clinical and Translational Science
X-ORIGINAL-URL:https://clinicaltrials.rbhs.rutgers.edu
X-WR-CALDESC:Events for New Jersey Alliance for Clinical and Translational Science
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20211129T090000
DTEND;TZID=UTC:20211129T094500
DTSTAMP:20260502T071817
CREATED:20211124T181239Z
LAST-MODIFIED:20211124T181841Z
UID:26166-1638176400-1638179100@clinicaltrials.rbhs.rutgers.edu
SUMMARY:University of North Carolina Clinical Science Institute TL1 William Schnaper Visiting Scientist Program Event
DESCRIPTION:Neutralizing Antibody Suppression: Overcoming a Natural Barrier to Viral Vectored Gene Therapies \nSpeaker: Charlie Askew\, Post Doctoral Fellow\, UNC Gene Therapy Center\nView Flyer \nJoin via Zoom!
URL:https://clinicaltrials.rbhs.rutgers.edu/event/university-of-north-carolina-clinical-science-institute-tl1-william-schnaper-visiting-scientist-program-event/
END:VEVENT
END:VCALENDAR